Developing Countries: Vaccine Access
2009/2720(RSP)
Flu Epidemic
2009/2602(RSP)
C(2021) 8740(final) of 26 November 2021 amending the conditional marketing authorisation granted by Decision C(2020)
2021/3052(RSP)
Amending the marketing authorisation granted by Decision C(2022) 7342(final) for “Comirnaty - tozinameran, COVID-19
2022/2991(RSP)
Comirnaty Vaccine Authorisation
2022/2941(RSP)
Granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for
2022/2928(RSP)
Gardasil 9: Marketing Objection
2023/2623(RSP)
EU Global Health Strategy
2023/2642(RSP)